Date | Insider | Price | Amount |
---|---|---|---|
3-2-2020 Insider Buy |
John L. Workman Director |
$94.63 CAGR » |
$189,264.00 2,000 shares |
11-6-2018 Insider Buy |
Heather L. Cohen EVP CORP HR |
$68.60 CAGR » |
$61,741.89 900 shares |
1-3-2018 Insider Buy |
Charles Farkas Director |
$50.61 CAGR » |
$7,996.38 158 shares |
10-3-2017 Insider Buy |
Charles Farkas Director |
$53.96 CAGR » |
$7,986.08 148 shares |
7-5-2017 Insider Buy |
Charles Farkas Director |
$50.78 CAGR » |
$7,972.46 157 shares |
4-3-2017 Insider Buy |
Charles Farkas Director |
$44.41 CAGR » |
$7,993.80 180 shares |
3-13-2017 Insider Buy |
Heather L. Cohen EVP CORP HR |
$40.00 CAGR » |
$17,598.24 440 shares |
3-10-2017 Insider Buy |
Curt R. Hartman President & CEO |
$40.11 CAGR » |
$322,115.43 8,030 shares |
3-6-2017 Insider Buy |
Mark E. Tryniski Director |
$41.15 CAGR » |
$205,750.00 5,000 shares |
1-3-2017 Insider Buy |
Charles Farkas Director |
$44.65 CAGR » |
$13,618.25 305 shares |
10-3-2016 Insider Buy |
Charles Farkas Director |
$40.04 CAGR » |
$13,453.44 336 shares |
7-1-2016 Insider Buy |
Charles Farkas Director |
$47.87 CAGR » |
$13,499.34 282 shares |
4-1-2016 Insider Buy |
Charles Farkas Director |
$42.04 CAGR » |
$14,209.58 338 shares |
3-2-2016 Insider Buy |
John L. Workman Director |
$39.85 CAGR » |
$99,631.25 2,500 shares |
1-29-2016 Insider Buy |
Curt R. Hartman President & CEO |
$36.32 CAGR » |
$181,621.00 5,000 shares |
1-4-2016 Insider Buy |
Charles Farkas Director |
$42.18 CAGR » |
$14,004.72 332 shares |
12-11-2015 Insider Buy |
David M. Bronson Director |
$41.01 CAGR » |
$61,522.05 1,500 shares |
10-1-2015 Insider Buy |
Charles Farkas Director |
$47.74 CAGR » |
$13,939.08 292 shares |
8-6-2015 Insider Buy |
Curt R. Hartman President & CEO |
$55.93 CAGR » |
$111,852.00 2,000 shares |
7-28-2015 Insider Buy |
John L. Workman Director |
$57.83 CAGR » |
$115,659.30 2,000 shares |
5-6-2015 Insider Buy |
Pat Beyer President-Conmed International |
$53.36 CAGR » |
$266,800.00 5,000 shares |
7-31-2014 Insider Buy |
Curt R. Hartman Interim CEO |
$39.25 CAGR » |
$392,496.00 10,000 shares |
Also See: Institutional Holders of CNMD
Also See: SEC filings
Growth of $10,000.00 With Dividends Reinvested |
|||
Start date: | 03/03/2020 | ||
End date: | 04/26/2024 | ||
Start price/share: | $96.24 | ||
End price/share: | $65.78 | ||
Starting shares: | 103.91 | ||
Ending shares: | 107.48 | ||
Dividends reinvested/share: | $3.40 | ||
Total return: | -29.30% | ||
Average Annual Total Return: | -8.02% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $7,069.72 | ||
Years: | 4.15 | ||
Growth of $10,000.00 Without Dividends Reinvested |
|||
Start date: | 03/03/2020 | ||
End date: | 04/26/2024 | ||
Start price/share: | $96.24 | ||
End price/share: | $65.78 | ||
Dividends collected/share: | $3.40 | ||
Total return: | -28.12% | ||
Average Annual Total Return: | -7.65% | ||
Starting investment: | $10,000.00 | ||
Ending investment: | $7,188.43 | ||
Years: | 4.15 |
CNMD Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent CNMD insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding CNMD
Free CNMD Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the CNMD Insider Buying occurred are:
DGSE Insider Buying |